Feb. 7, 2007 — Abbott has announced its plan to launch the world's first drug-eluting stent clinical trial solely in women. Performance of the Xience V Everolimus Eluting Coronary Stent System will be the focus of the SPIRIT WOMEN trial, designed specifically to study CVD in women and how it differs from men. Xience V is not FDA cleared for commercial sale in the U.S.

The first interwoven nitinol self-expanding stent available in the U.S. for palliative treatment of malignant strictures in the biliary tree, the SureSave Stent will be renamed SUPERA. SUPERA represents an advance over traditional laser cut nitinol tube stents in offering more than 360 percent greater radial strength than the next strongest offering. The increase in radial strength is due to the product's interwoven nitinol wire design.

Rapidly cooling a patient's core temperature, the ThermoSuit System consists of a disposable body suit and a means to pump coolant within the suit over the skin of the patient.

It is the first device for patient temperature management that provides a thin layer of rapidly flowing liquid coolant in direct contact with the skin.

The FDA has cleared St. Jude Medical’s Reflexion Spiral Variable Radius Mapping Catheter featuring a circular loop at the tip that expands from 15 mm to 25 mm to fit a variety of patient anatomies. It is the only variable radius circular mapping catheter available with bi-directional deflection, which provides enhanced versatility for complex left atrial procedures. It also features the proprietary ComfortGrip handle to give physicians improved comfort and control during electrophysiology (EP) procedures.

The new AngioJet Ultra Thrombectomy System is a next-generation, completely re-engineered version of Possis' AngioJet Rheolytic Thrombectomy System. AngioJet is marketed for blood clot removal (thrombectomy) from arterial and venous blood vessels.

A low osmolar, nonionic, iodinated contrast agent, the OMNIPAQUE has been used in more than 250 million patients worldwide. Its indications include a broad range of intravascular diagnostic procedures such as coronary angiography, spinal cord imaging and body cavity procedures including shoulder and knee joints. The injection is approved for use in adults and children.

The Avanta Fluid Management Injection System and the Vanguard Dx Angiographic Catheters give clinicians a single, flexible system for many cardiovascular imaging procedures.

Avanta is capable of controlled delivery of contrast at low flow rates and low pressures in variable mode to enable injections of small vessels, like the coronary arteries. For larger vessels and peripheral imaging needs, the injector can generate high flow rates and high-pressure injections in fixed mode.

Combining all of the features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi Contrast Delivery System for cardiovascular angiographic procedures enhances the ease of contrast and saline injection for physicians, nurses and technicians.

Boston Scientific’s LATITUDE 2.0 software with LATITUDE remote data integration capabilities is now FDA cleared. LATITUDE Patient Management is a remote monitoring system to provide clinicians with direct device data integration capability into GE’s Centricity Electronic Medical Record (EMR). The LATITUDE Web site also provides increased efficiencies to clinicians through streamlined system navigation and increased alert flexibility. Remote home monitoring is a tool to help physicians manage patients with heart failure and patients at risk of sudden cardiac death.

A new platform architecture for TeraRecon’s Aquarius suite of products, iNtuition is designed to deliver integration of advanced imaging workflow into the healthcare enterprise and features an improved and more powerful central rendering resource in the form of the VolumePro 2000, based on the company’s Aquarius product line and provides radiologists, technologists and referring physicians imp

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now